Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise 
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions 
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs 
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand 
ANZ Faces Legal Battle as Former CEO Shayne Elliott Sues Over A$13.5 Million Bonus Dispute 
Apple App Store Injunction Largely Upheld as Appeals Court Rules on Epic Games Case 
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
Moore Threads Stock Slides After Risk Warning Despite 600% Surge Since IPO 
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model 
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing 
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff 
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation 
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio 
Philip Morris International Inc. (NYSE: PM) is reportedly exploring the sale of its cigar business for over $1 billion, according to Bloomberg. The move aligns with the tobacco giant’s strategy to transition toward smoke-free products.
Philip Morris acquired the cigar unit through its 2022 purchase of Swedish Match, a deal aimed at expanding its smoke-free portfolio. Since then, the company has successfully introduced Swedish Match’s popular ZYN nicotine pouches in the U.S., fueling strong demand.
Despite this shift, traditional cigarettes, particularly the iconic Marlboro brand, remain a key revenue driver. While Philip Morris is pushing alternatives in the U.S., international sales still rely heavily on cigarette demand, especially in emerging markets.
The company recently reported better-than-expected fourth-quarter earnings and provided an optimistic outlook for 2025. Its IQOS smoke-free device is also gaining traction in the U.S., following FDA approval in early 2024.
With growing demand for smoke-free alternatives, Philip Morris’ potential cigar business sale marks another step in its transformation strategy.
